Hone Health, a leading longevity platform, announced on Wednesday that it has raised $228 million in financing to support its expansion and enhance its services.
The direct-to-consumer company offers access to biomarker testing, physician consultations, and personalized treatments for various health concerns, including menopause, weight management, thyroid issues, heart health, and sexual health. Hone Health has supported more than 200,000 patients to date.
“Many people, including myself, have been failed by the current healthcare system,” said Saad Alam, co-founder and CEO of Hone Health. “While individuals now have unprecedented access to data about their own bodies, they often lack guidance on how to act on it. Hone Health aims to address this by providing deep insights into health metrics, empowering people to make informed decisions about their health and longevity.”
The financing was led by MarcyPen Capital Partners, with participation from Pentland Ventures, Kinship Ventures, Hanwha, Gannet Capital, humbition, Comma Capital, and ID Ventures. The funding includes $28 million in equity as Series A financing, along with $200 million in growth financing from General Catalyst’s Customer Value Fund.
Gwyneth Paltrow, actress and founder of wellness company Goop, is also a co-founder of Kinship Ventures. She noted the significant growth in the wellness sector.
“When I started goop, wellness was a niche conversation,” Paltrow said. “Today, it’s one of the biggest categories in the world, and the next step is bringing genuine health and wellness to the masses, not just a privileged few. Saad has built Hone Health to do exactly that, with robust science and at real scale. That’s why Kinship invested, and we are incredibly excited about what’s ahead.”
The funding will be used to support expansion in five key areas, according to the announcement:
- Launching and scaling programs for metabolic health, PMOS, inflammation, and immunity
- Integrating diagnostic tools into longitudinal patient care, such as MRIs and gut microbiome testing
- Enhancing AI technology to help clinicians personalize care
- Introducing a physician-supervised peptide program
- Advancing clinical trials infrastructure
In addition to the funding, Hone Health announced the launch of Hone Black, a new premium membership program that includes access to testing for over 1,600 biomarkers; comprehensive care across hormonal, metabolic, and cognitive health; a dedicated concierge team; and advanced treatments. The program has been in stealth development for the past year.
“Hone Black is our most comprehensive concierge longevity membership to date, combining extensive diagnostics with ongoing care from a dedicated team of physicians responsible for a whole-body care plan,” Alam said.
Alam added that Hone Health ultimately aims to build a research platform that improves health outcomes and helps people live longer, healthier lives.
Photo: Richard Drury, Getty Images

